Consistentwith this, a dual PI3K/mTOR inhibitor PF-04691502 has been found to displaysynergistic cytotoxicity with quizartinib in FLT3-ITD AML cells (42). The gene discussed is FLT3; the disease is acute myeloid leukemia.